More on ENSC

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+10.1% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/19/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Ensysce Biosciences (NQ:ENSC)
Delayed: 0.30 --0 (-0%)
Prev. Close $0.30  
Open$0.30 
52 Wk High$ 
52 Wk Low$ 
Day High$0.31 
Day Low$0.29 
P/E N/A  
EPS$ 
Volume588,165 

Friends, Peers and Foes (?): PLTR RXT (more...)

Jun 29, 2026 06:03 AM Form EFFECT Ensysce Biosciences,
Jun 26, 2026 08:02 AM Ensysce Biosciences begins final phase of opioid overdose study
Jun 26, 2026 08:01 AM Ensysce Biosciences Enrolls First Patient in Final Phase of PF614-MPAR-102 Clinical Study
Jun 4, 2026 04:43 PM Form S-3 Ensysce Biosciences,
May 22, 2026 04:55 PM Form 8-K Ensysce Biosciences, For: May 22
May 15, 2026 04:27 PM Form 10-Q Ensysce Biosciences, For: Mar 31
May 15, 2026 04:27 PM Form 8-K Ensysce Biosciences, For: May 15
May 15, 2026 04:15 PM Ensysce Biosciences Reports First Quarter 2026 Financial Results
May 12, 2026 08:09 AM Ensysce Biosciences receives Taiwan patent for overdose protection technology
May 12, 2026 08:08 AM Ensysce Biosciences Announces Expansion of Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology
View All Articles

Entities mentioned with ENSC

View All Entities